FIELD: organic chemistry of heterocyclic compounds, biochemistry.
SUBSTANCE: invention relates to new ortho-substituted and N-substituted indoles of the formula (α): or (β): or their pharmaceutically acceptable salts wherein Z1 represents -CR4 or nitrogen atom (N); R4 means hydrogen atom (H), (C1-C6)-alkyl comprising optionally oxygen atom (O) or nitrogen atom (N) possibly substituted with halogen atom, keto-group, 5-6-membered cycloaliphatic radical possibly comprising 1-2 oxygen atoms (O) or nitrogen atom (N); Z2 represents -CH or -CR wherein R means (C1-C6)-alkyl; R1 means compound of the formula: wherein X1 means -CO or its isostere; m = 0, 1; Y represents alkyl that can be substituted; or two Y form in common (C2-C3)-alkylene; n = 0, 1 or 2; Z3 represents -CH; X2 represents -CH, -CH2 or their isostere; Ar represents one or two phenyl groups bound with X2 wherein phenyl can be substituted; R2 represents hydrogen atom (H), (C1-C6)-alkyl or aryl wherein each aryl comprises, possibly, oxygen atom (O) or nitrogen atom (N) and can be substituted. Proposed compounds are selective inhibitors of p38α kinase.
EFFECT: valuable biochemical properties of compounds.
34 cl, 5 tbl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF INDOLE ORDER AS p38 KINASE INHIBITORS | 2000 |
|
RU2278115C2 |
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
MINERALOCORTICOID RECEPTOR ANTAGONISTS | 2012 |
|
RU2598842C2 |
ESTROGEN RECEPTOR PROTEOLYSIS MODULATORS AND RELATED USES THEREOF | 2018 |
|
RU2797808C2 |
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
SUBSTITUTED AMIDES, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD OF TREATING DISEASES SENSITIVE TO Btk, METHOD OF INCREASING SENSITIVITY OF CANCER CELLS TO CHEMOTHERAPY, METHOD OF REDUCING ERRORS WHEN TAKING MEDICINE AND IMPROVING OBSERVATION OF TREATMENT SCHEDULE, METHOD OF INHIBITING HYDROLYSIS OF ATP, METHOD OF DETERMINING PRESENCE OF Btk IN SAMPLE AND METHOD OF INHIBITING ACTIVITY OF B-CELLS | 2008 |
|
RU2470923C2 |
Authors
Dates
2006-02-27—Published
1999-05-21—Filed